Citius Oncology Inc.CTORNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank25
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-22.38M
↓ 27% vs avg
Percentile
P25
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-17.66M
Historical baseline
PeriodValueYoY Change
TTM$-22.38M+4.9%
2025$-23.52M-14.3%
2024$-20.57M-69.7%
2023$-12.12M-24.8%
2022$-9.71M-